Akos Czibere

Executive

Insider activity · 24 months0 buys5 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 3 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 2 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (5 ops.)

€1.4M

Latest filing published 24 Sept 2026 for AKTIS ONCOLOGY, INC., €54k.

Filing timeline

BuySale

Akos Czibere

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Akos Czibere: trading record in brief

Akos Czibere is a declared insider of Aktis Oncology, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 8 July 2026 to 23 September 2026, the count stands at 7 filings.

Every open-market trade on record is a sale: 5 sales worth €1.4M. Besides market trades, the filings include 2 option exercises.

The record was last updated on 24 September 2026 with an option exercise (€54k) in Aktis Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.